WellMedr
Sells an eight-product low-dose line alongside brand Ozempic and Zepbound — and prices the tirzepatide the same at every dose.
- Semaglutide
- $59/mo on a 12-month plan
- Tirzepatide
- $99/mo on a 12-month plan
- Coverage
- Coverage not published
- Brand-name
- Yes
Weigh WellMedr against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.
Factor breakdown
Each of the six graded dimensions. See the methodology.
Strengths
- Eight named microdose products across oral and injectable routes, each with its formulation published — a real low-dose line, not a smaller amount of a standard plan
- States its dose basis outright on the tirzepatide plan: "Same price regardless of dosage"
- Publishes what a "month" contains — both plans say "shipped every 4 weeks" on the plan card itself
- Names the treating clinical group in its telehealth consent: OpenLoop Health, Inc. and its state professional corporations
- Names both halves of the supply chain: OpenLoop Health, Inc. as the medical group and "Mycelium Pharmacy — our U.S.-licensed fulfillment pharmacy" as the dispenser — most compounded sellers name neither
- Puts the compounding caveat on the pricing page, not in a footer: compounded medications are "regulated by state Boards of Pharmacy, but are not evaluated by the FDA for safety or efficacy", with explicit thyroid C-cell tumor and MTC warnings
- Offers FDA-approved brand product — Ozempic from $1,399, Zepbound from $1,599 — for anyone who decides against compounded
Where it loses points
- The microdose page headlines "ZERO Side Effects", subheaded "Zero side effct for 70%+ of members" (their typo) — an unqualified claim no evidence supports, on a page that carries no safety notice at all — the thyroid C-cell tumor warning is on the pricing page, not this one
- ITS FAQ SAYS THE MEDICATIONS ARE FDA APPROVED. Asked "Are these medications FDA approved?", the page answers "Yes. We only work with U.S. licensed pharmacies that dispense FDA-approved medications" — while the footer of that same page says they are "not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality". A buyer asking the one regulatory question that matters is told the opposite of the truth
- TWO DIFFERENT BILLING CYCLES ARE PUBLISHED. The plan cards say "shipped every 4 weeks" — 13 charges a year — while the refund policy says the subscription "will automatically renew every 21 days", which is about 17. Which one your card sees is not knowable from the site
- The advertised $59 is a twelve-month rate — the banner reads "Lock In $200 OFF Every Month, or $59/mo on 12/month Plans — For Life". It names only that figure; the $99 tirzepatide card carries no such condition and says "Cancel or change anytime". Yet no standing month-to-month rate is published for either molecule
- A "month" is four weeks on both plans, so a year is 13 charges rather than 12 — about 8.6% more than the monthly label implies
- Six of the eight microdose products publish no price at all; the two that do both show $199/month regardless of formulation
- The semaglutide plan makes no statement about dose basis in either direction, so whether a low dose costs less there is simply unknown
- Two discounts stack — "$200 OFF Every Month" and a separate "$150 off for Life" — and neither reverses into a standing rate
- The results carousel is disclosed as "Inspired by real patient success stories in similar Telehealth programs", so those figures are not WellMedr patients
- The top bar advertises "FDA-regulated pharmacies" — a claim about the pharmacy, not the drug
- The pharmacy is named only in the privacy policy — not on the pricing page, the microdose page or anywhere a buyer would look for it
Bottom line — Grade C
Best for: Shoppers who want a named low-dose product, an oral route, or a path to brand-name GLP-1 without changing providers.
Ranked #218 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.
Closest here
The rankings grading nearest WellMedr — the realistic shortlist.
Green Cap Health is a Texas-only telehealth practice with a vertically integrated model: it is both the prescribing clinical practice and the in-house compounding pharmacy.
Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.
RxSaludable is a Spanish-language GLP-1 weight-loss telehealth service (atencion en espanol) offering compounded semaglutide from $99 the first month ($179/mo after) and tirzepatide from $189 the first month, prescribed by U.S.-licensed, Spanish-speaking providers and shipped free.
TRT Nation is a men's telehealth platform focused primarily on testosterone replacement therapy, with compounded GLP-1 weight loss as a secondary vertical.
June Health is a direct-to-consumer telehealth storefront selling compounded GLP-1 medication for weight loss, alongside peptide, hormone, and hair-loss programs, all delivered online with no office visits.
LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss.
The 24 rankings nearest this one
- #219 10rx66.1
- #220 boostAGErx66.1
- #221 Ivologist66.1
- #222 Lumora66.1
- #223 MediRX66.1
- #224 NiceRx66.1
- #225 Rejuve Meds66.1
- #226 TeleHealth Med66.1
- #227 altRX66
- #228 Coby Health66
- #229 PCOS Sisters66
- #230 Amble65.8
- #231 Neo Soma Healthcare65.8
- #232 Zeuss65.8
- #233 FMmeds65.7
- #234 Eloria65.6
- #235 FuturHealth65.6
- #236 Healthicare65.5
- #237 NowPatient65.5
- #238 Options Medical Weight Loss65.5
- #239 Primary Clinic (Direct GLP)65.5
- #240 Shapely65.4
- #241 Enara Health65.3
- #242 RestorLife Med65.3
Pricing/verification reflect WellMedr's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on WellMedr's site. Not medical advice; see our disclosure.